Design of experiments optimization of N,N,N-trimethyl chitosan synthesis using N,N-diisopropylethylamine base.

Chemical modification Chitosan Design of experiments (DoE) Optimization Trimethyl chitosan (TMC)

Journal

Carbohydrate research
ISSN: 1873-426X
Titre abrégé: Carbohydr Res
Pays: Netherlands
ID NLM: 0043535

Informations de publication

Date de publication:
16 Oct 2024
Historique:
received: 04 09 2024
revised: 10 10 2024
accepted: 15 10 2024
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 20 10 2024
Statut: aheadofprint

Résumé

This study presents a novel synthesis method of N,N,N-trimethyl chitosan (TMC) by using a non-nucleophilic base and optimizing the solvent system for enhanced scalability, while addressing critical factors such as viscosity management and stirring efficiency. The study objectives also included achieving high N,N,N-trimethylation without O-methylation while minimizing reagent use. Eight bases, three solvent systems, and varying levels of dilution were explored to mitigate viscosity challenges and gas evolution.

Identifiants

pubmed: 39427434
pii: S0008-6215(24)00268-4
doi: 10.1016/j.carres.2024.109289
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109289

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Vivien Nagy reports financial support was provided by The Icelandic Centre for Research. Helene Liette Lauzon reports a relationship with Primex ehf. that includes: employment. Mar Masson has patent #Chitosan derivatives and methods for preparing the same issued to Primex ehf. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Vivien Nagy (V)

Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Hofsvallagata 53, IS-107, Reykjavík, Iceland.

Bergthóra S Snorradóttir (BS)

Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Hofsvallagata 53, IS-107, Reykjavík, Iceland.

Héléne Liette Lauzon (HL)

Primex ehf, Oskarsgata 7, IS-580, Siglufjordur, Iceland.

Már Másson (M)

Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Hofsvallagata 53, IS-107, Reykjavík, Iceland. Electronic address: mmasson@hi.is.

Classifications MeSH